RareCyte

About:

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Website: https://rarecyte.com/

Twitter/X: RareCyte

Top Investors: F-Prime Capital, The Forest Road Company, Agilent Technologies, Logos Capital, HealthQuest Capital

Description:

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to the Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. RareCyte's AccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells (CTCs) and circulating endothelial cells (CECs) from whole blood.